Skip to main content
Premium Trial:

Request an Annual Quote

Geospiza Awarded SBIR Grant to Develop Application for Cancer DNA Variations

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Geospiza today announced it has received a $1.2 million Small Business Innovation Research Grant to develop a new application that can identify and visualize DNA sequence variations in cancer tissue compared to normal tissue.

The Seattle-based bioinformatics software firm will collaborate with researchers from Weill Cornell Medical College in New York and the Mayo Clinic in Rochester, Minn., to develop the new application on GeoSpiza's GeneSifter cloud computing platform.

The two-year grant is from the National Human Genome Research Institute.

David Smith, a professor of laboratory medicine and pathology at the Mayo Clinic, said that new sequencing technologies have opened new avenues of cancer biology research.

"It's clear that the next generation of diagnostic tests can only be made by effectively combining whole transcriptome analysis with genome sequences on a per patient per sample basis," he said in a statement. "The application developed through this work will be well suited for translating research observations to actionable clinical tests."

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.